Cargando…

Commentary: Vagal P2RY1 Receptors: A Novel Target for Airway Disease

Detalles Bibliográficos
Autores principales:	Liu, Juan, Hu, Yu-Shi, Tang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774324/ https://www.ncbi.nlm.nih.gov/pubmed/33390983 http://dx.doi.org/10.3389/fphar.2020.596003

Ejemplares similares

Calcium, a multitasking signaling actor in airway smooth muscle cells, as a target of novel strategies to limit airway disease?
por: Tanguy, Stephane
Publicado: (2015)

Long-Term Effects of Ivabradine on Cardiac Vagal Parasympathetic Function in Normal Rats
por: Scridon, Alina, et al.
Publicado: (2021)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Commentary: Vagal Tank Theory: The Three Rs of Cardiac Vagal Control Functioning – Resting, Reactivity, and Recovery
por: Hottenrott, Laura, et al.
Publicado: (2019)

Flecainide induces a sustained countercurrent dependent effect on RyR2 in permeabilized WT ventricular myocytes but not in intact cells
por: Steer, Emma J., et al.
Publicado: (2023)

The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
por: Alves, Mariana, et al.
Publicado: (2018)

Soft TCPTP Agonism—Novel Target to Rescue Airway Epithelial Integrity by Exogenous Spermidine
por: Ghisalberti, Carlo A., et al.
Publicado: (2016)

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
por: Fang, Yanglan, et al.
Publicado: (2022)

P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease
por: Zhou, Junteng, et al.
Publicado: (2021)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Simko, Fedor, et al.
Publicado: (2022)

Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting
por: Maione, Francesco
Publicado: (2016)

Arginine Vasopressin Alters Both Spontaneous and Phase-Locked Synaptic Inputs to Airway Vagal Preganglionic Neuron via Activation of V(1a) Receptor: Insights into Stress-Related Airway Vagal Excitation
por: Yan, Xianxia, et al.
Publicado: (2017)

Mrgprs on vagal sensory neurons contribute to bronchoconstriction and airway hyperresponsiveness
por: Han, Liang, et al.
Publicado: (2018)

The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity
por: Reznikov, Leah R., et al.
Publicado: (2018)

Commentary: Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications
por: Salem, Abdelhakim, et al.
Publicado: (2020)

Targeting NMDA receptor in Alzheimer’s disease: identifying novel inhibitors using computational approaches
por: Siddiqui, Arif Jamal, et al.
Publicado: (2023)

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021)

miR-378b Regulates Insulin Sensitivity by Targeting Insulin Receptor and p110α in Alcohol-Induced Hepatic Steatosis
por: Li, Yuan-yuan, et al.
Publicado: (2020)

Population-Specific Associations of Deleterious Rare Variants in Coding Region of P2RY1–P2RY12 Purinergic Receptor Genes in Large-Vessel Ischemic Stroke Patients
por: Janicki, Piotr K., et al.
Publicado: (2017)

P2RY14 downregulation in lung adenocarcinoma: a potential therapeutic target associated with immune infiltration
por: Xu, Ting, et al.
Publicado: (2022)

Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice
por: Yang, Yang, et al.
Publicado: (2021)

The Safeguarding Microglia: Central Role for P2Y(12) Receptors
por: Lin, Si-Si, et al.
Publicado: (2021)

Common variants in P2RY11 are associated with narcolepsy
por: Kornum, Birgitte R, et al.
Publicado: (2010)

Characterization of the Vagal Motor Neurons Projecting to the Guinea Pig Airways and Esophagus
por: McGovern, Alice E., et al.
Publicado: (2010)

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
por: Merighi, Stefania, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

The enigmatic role(s) of P2RY8-CRLF2
por: Panzer-Grümayer, Renate, et al.
Publicado: (2017)

Microglia and Neuroinflammation: What Place for P2RY12?
por: Gómez Morillas, Albert, et al.
Publicado: (2021)

Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Vagal mechanisms as neuromodulatory targets for the treatment of metabolic disease
por: Berthoud, Hans‐Rudolf, et al.
Publicado: (2019)

P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders
por: Franklin, Kelle M., et al.
Publicado: (2014)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Vaccination on E. I. Ry.
por: Waters, H. G.
Publicado: (1917)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Association Between the P2RY12 Receptor Gene Polymorphism and Aspirin Resistance in Patients with Coronary Artery Disease
por: Karazhanova, Ludmila, et al.
Publicado: (2014)

Commentary: Astroglial CB(1) Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory
por: Guo, Yan-Chen, et al.
Publicado: (2018)

Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution
por: Yan, Zhen, et al.
Publicado: (2014)

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016)

Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders
por: Christian, Sherri L., et al.
Publicado: (2018)

Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 Protein
por: Cacheux, Marine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s3lf1jicoe4hfnsgg80askp6s7